NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX)
Post# of 231
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its senior vice president of intellectual property and licensing, Thomas Gallagher, will participate at the annual NYC-based Life Sciences Summit. Gallagher will take part in a panel discussion titled, “Show Me the Money: Preparing Your Company for Funding,” at the event, slated to place virtually November 17-18, 2020. During the panel discussion, scheduled for 10-10:45 a.m. ET on Tuesday, November 17, experts will provide insight into the essential building blocks needed for emerging companies to reach their goals. Interested parties should visit https://nnw.fm/00HIV to register for the event.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer